Training older adults to better perceive airflow limitations in asthma
Official title: A randomized trial of perception of airflow limitation training to improve outcomes for older adults with asthma
Funded at Icahn School of Medicine at Mount Sinai · NIH-11003310 · Data updated 2026-11-12
This study is looking to help older adults with asthma by teaching them how to better recognize their breathing patterns, so they can manage their condition more effectively and feel better overall.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | December 22, 2023 |
| Project end | November 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $670,888 |
| NIH project number | 5R01HL171676-02 |
| Project ID | NIH-11003310 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are older adults over 60 years old who have been diagnosed with asthma.
✕Less likely to help
Patients who are younger than 60 or do not have a diagnosis of asthma may not benefit from this research.
What this research studies
This research focuses on improving asthma outcomes for older adults by enhancing their awareness of airflow limitations. It involves a randomized controlled trial where participants will receive training to better perceive their expiratory airflow through feedback from peak expiratory flow measurements. The study also incorporates motivational interviewing to encourage better self-management of asthma. By understanding how this training affects asthma control, the research aims to provide valuable insights into improving care for older adults with asthma.
Why it matters
Potential benefit: If successful, this research could lead to improved asthma management and reduced hospitalizations for older adults.
How similar studies have gone: Previous pilot studies have shown promising results in improving asthma control through similar training approaches, indicating potential for success in this larger trial.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Wisnivesky, Juan P — Icahn School of Medicine at Mount Sinai
- Study coordinator: Wisnivesky, Juan P
Related research
Other NIH-funded projects on the same topics.
-
GLP-1 receptor agonists as immune targets to treat asthma in lean and obese adults
Aims to understand how GLP-1R‑agonist diabetes medicines may directly calm immune cells to reduce asthma in adults who are lean or obese.
-
Understanding how a type of immune cell called ILC2s affect asthma in adults
This grant studies how group 2 innate lymphoid cells influence asthma in adults to help identify new ways to manage airway inflammation.
-
Expanding understanding of asthma in kids through airways and blood profiling
A study at UC San Francisco will profile blood and nasal/sputum samples from 300 youth (including 200 with asthma) over a year to understand how environmental and social factors influence asthma in marginalized communities.
-
Preventing and improving asthma care for children in urban communities
This program will try several approaches — from giving helpful bacteria to babies to allergy immunotherapy and advanced airway testing — to prevent and better treat asthma in children who live in cities.
-
IDEAL project helps predict vaccine response, infections, and asthma in early childhood
A Child-focused program will collect and share saliva, blood, and tissue samples from diverse infants to find biological patterns that predict how vaccines work, how respiratory infections occur, and who develops asthma.
-
Understanding how early-life immune development affects vaccine responses and asthma risk in children
This project uses lab-grown human immune cells from infants and young children to explore why some kids respond poorly to vaccines and are more prone to respiratory infections and asthma.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.